Welcome!

News Feed Item

Drug Discovery Technologies - A Global Market Overview

NEW YORK, Sept. 1, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:  Drug Discovery Technologies - A Global Market Overview

http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening.

Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Others comprising Epigenetics, Metabolomics, Combinatorial Chemistry, Synthetic Biology, Systems Biology and Nanotechnology.

The global market value for the above mentioned technologies is analyzed in USD. High Throughput Screening accounts for a lion's share in global drug discovery technologies market with an expected share of about 30% in 2015 valued at $18 billion followed by Bioanalytical Assays or instruments by about $14 billion.

This 248 pages global market report includes 28 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 56 key global players and 67 major players across the United States – 41; Europe – 16; Asia-Pacific – 7; and Rest of World - 3. The research also provides the listing of the companies that are engaged in technology, contract research services and providers of discovery technologies. The global list of companies covers addresses, contact numbers and the website addresses of 186 companies.

TABLE OF CONTENTS:

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

1.1 Product Outline

1.1.1 Backdrop

1.1.2 What Is Drug Discovery?

1.1.2.1 Screening and Design

1.1.3 Omics in Drug Discovery and Development

1.1.4 Process of Discovering Improved Drugs Provided by a Technological Revolution

1.1.5 Drug Discovery Technologies

1.1.5.1 Bioanalytical Assays

1.1.5.1.1 Bio-Analytical Techniques

1.1.5.1.2 Sample Extraction

1.1.5.2 Bioinformatics

1.1.5.2.1 Computer-Aided Drug Design

1.1.5.3 Cell Based Assays

1.1.5.3.1 Cell-Based Assays in High-Throughput Screening for Drug Discovery

1.1.5.4 Genomic Technologies

1.1.5.4.1 Drug Discovery

1.1.5.4.2 Clinical Medicine

1.1.5.4.3 New Antibiotics

1.1.5.5 High Throughput Screening

1.1.5.5.1 High Throughput Screening in Drug Discovery

1.1.5.6 Proteomic Technologies

1.1.5.6.1 A Proteomics Approach to Biomarker Discovery and Drug Development

1.1.5.7 Other Technologies

1.1.5.7.1 Epigenetics

1.1.5.7.1.1 Epigenetics and Cancer Treatment

1.1.5.7.2 Metabolomics

1.1.5.7.2.1 Target Identification

1.1.5.7.2.2 Target Validation

1.1.5.7.2.3 Lead Optimization

1.1.5.7.2.4 Mode of Action

1.1.5.7.2.5 Preclinical Studies

1.1.5.7.2.6 Clinical Studies

1.1.5.7.2.7 Post-Approval Studies

1.1.5.7.2.8 Diagnostics

1.1.5.7.3 Combinatorial Chemistry

1.1.5.7.3.1 Chemical Encoding

1.1.5.7.3.2 Positional Encoding

1.1.5.7.3.3 Electronic Encoding

1.1.5.7.4 Synthetic Biology

1.1.5.7.5 Systems Biology

1.1.5.7.5.1 Computer Modelling

1.1.5.7.6 Nanotechnology

2. KEY MARKET TRENDS

2.1 Drug Discovery Gets Faster, Smarter and Cheaper

2.2 Drug Discovery Being Enabled through Halogen Bonds

2.3 Drug Discovery Bolstered by New Use for Stem Cells in Targeting ALS

2.4 Personalized Medicine: Advantage Patients, Disadvantage Drug Companies

2.5 Identification of Diagnostic and Therapeutic Targets Better Enabled by Combining Plasma Screening and Genetic Screening

2.6 Source of New Drug Category from Trapping Malaria Parasites inside Host Blood Cell

2.7 Fighting Malaria Drug Resistance through an Innovative Method

2.8 Drug Screening in 3D Using High-Throughput Chip

2.9 Drug Discovery Expedited through 3D Protein Mapping

2.10 Drug Discovery and Automated Cell Staining

2.11 Drug Discovery and Development for Complex Disease Targets to be Alleviated through a Computer Program

3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE

USPTO Issues '979 Patent for Biohaven's Glutamate Modulating Agents to Treat GAD

Patents Issued for Suven's New Chemical Entities to treat Neurodegenerative Disorders

Japan Patent Office Approves Patent for C4XD's Technology

Additional Patents Issued on MorphoSys' Ylanthia in the US and in China

Sareum Receives a Patent for its Kinase Inhibitors in Japan

USPTO Grants Patent for Prima BioMed's CVac

Japan Patent Office Decides to Issue Patent for Marina's SMARTICLES® Nucleic Acid Delivery Technology

USPTO Grants a Patent in Regulus' Sarnow Patent Estate on microRNA Therapies to Treat HCV

USPTO Grants Patent for Kadimastem's Cell Technology

USPTO Grants a Novel Patent in Alnylam's McSwiggen Patent Estate

Suven Receives Patent Approval in the US for its Major Depressive Disorder Drug

Notice of Allowance for Canadian Patent Granted to VistaGen

Issue of Patent on Broad Institute's New Gene-Editing Method

US Patent Office Grants Patent for HUB's Method of Growing Organoids

Dyadic Granted US Patent for High Throughput Screening

US Patent Granted to Theranostics Health

Reveleris Flash Chromatography System Receives Patent from the Australian Patent Office

Sareum Receives Patent for one of its CHK1 Cancer Programme-related Inventions in the US

Lpath's iSONEP Receives Patent from USPTO

KeyGene Obtains Patent for High Throughput Screening in the US

BioInvent's F.I.R.S.T. Drug Discovery Technology Gets Patent in the US

Plasticell Receives Additional Patents for its CombiCult® Cell Culture Technology in the US, Europe, Australia and Singapore

EntomoPharm Receives Patent for its BBB Insect Model in Europe

Summit Gets Patent for Utrophin Modulator SMT C1100 in the US

USPTO Grants Patent to OncoMed for Methods of Treating Cancer with its Antibody Vantictumab

Novel Component of Phylomer® Peptide Platform Patented by Phylogica for Advanced Cell-Penetrating Drug Discovery

COTI Receives Two Newly Granted Patents for its Lead Oncology Asset in the US

4. KEY GLOBAL PLAYERS4-Antibody AGAbbott LaboratoriesAccelrys, Inc.Affymetrix Inc.Agilent Technologies Inc.Asahi Kasei Pharma CorporationAstrazeneca PlcAviva Biosciences Corp.Bayer Healthcare AGBD BiosciencesBeckman Coulter Inc.Biacore International ABBioanalytical Systems, Inc.Bio-Rad Laboratories, Inc.Boehringer Ingelheim GmbHBristol-Myers Squibb CompanyCaliper Life Sciences, Inc.Caprion Proteomics, Inc.Celera CorporationCelgene CorporationCharles River Laboratories International, Inc.Compugen Ltd.Decode Genetics, Inc.EMD Millipore CorporationEvotec AGGE Healthcare Ltd.Genedata AGHitgen LtdHudson Robotics, Inc.Illumina Inc.Incyte CorporationIsis Pharmaceuticals, Inc.Kyowa Hakko Kirin Co., Ltd.Luminex CorporationMaxcyte, IncMerck & Co., Inc.Millennium Pharmaceuticals, Inc.Molecular Devices, LLCMolecular Discovery Ltd.Molecular Discovery Systems Pty., Ltd.New England Biolabs, Inc.Novartis AGOsiris Therapeutics Inc.Perkinelmer, Inc.Promega CorporationQiagen N.V.Quantum PharmaceuticalsRoche Holding AGShimadzu CorporationSigma-Aldrich CorporationSri BiosciencesTecan Group Ltd.The National Center for Drug ScreeningThermo Fisher Scientific Inc.Viva Biotech LtdWaters Corp.

5. KEY BUSINESS TRENDS

Evotec Established Alliance with Eternygen on New Small Molecule Inhibitors Development

MRC Technology Partnered With Daiichi Sankyo to Discover New Drug Targets

Evotec, Debiopharm Group™ to Discover New Drugs to treat Cancer

Daiichi Sankyo Forms Alliance with UCSF on New Cures Development to Treat Neurodegenerative Diseases

Debut of a Synergetic Drug Discovery Project for 2014 by Daiichi Sankyo

Analgesic Drug Discovery and Development Collaboration Formed by Convergence and Evotec

MIT SBC, Pfizer Enter into a Three-Year Drug Discovery Research Alliance

Abide, Celgene Partners to Discover and Develop Novel Drugs to Treat Inflammation and Immunological Disorders

Novel Genetic Platform Having the Ability to Yield Natural Microbial Genomes

Johnson & Johnson Innovation Signs Novel Agreements with NEOMED and MaRS Innovation

Boehringer Ingelheim and Circuit Therapeutics Form Drug Discovery Research Pact for Three Years

Life Technologies and NCATS form RNAi Research Alliance to Enhance Novel Therapeutics Discovery

Novel Core Unit of USTAR and U of U Eases Pharmacological Therapeutic Development

JHL Biotech Inks Strategic Collaboration with Selexis to Develop Biologic Drugs

Bayer Offer Funding to the SGC for Expediting Drug Research

HitGen, the University of Manchester's Cancer Research UK Manchester Institute Drug Discovery Group and Cancer Research Technology Form Drug Discovery Pact

BioFocus, Boehringer Ingelheim Enter Into Drug Discovery Pact

Evotec Establishes Drug Discovery Alliance with Johnson & Johnson Innovation on AD Targets

Release of GE Healthcare Life Sciences' Novel Xuri™ Technology Family

4SC Discovery, CRELUX and AiCuris Form Drug Discovery Pact

Novel SLAP Technology for Drug Discovery Advancements

Inauguration of GE Healthcare Life Sciences Technology Laboratory at the UK's First Open Innovation Bioscience Campus

Debut of an "Open Innovation" Research Alliance by AstraZeneca and Taiwan's NRPB to Accelerate Drug Discovery

Asahi Kasei Pharma and Vernalis plc Collaborate to Discover Drugs for Autoimmune Diseases

Launch of Thermo Fisher Scientific's Novel Innovations at BioProcess International Conference and Exhibition

Adimab Establishes Alliance with Celgene on Multi-target Discovery

Eurofins Scientific, GE Healthcare Enter Pact on Drug Discovery Services

Debut of Boehringer Ingelheim and Polyphor into the Next Research Stage of their Alliance

Commercial Release of Agilent's RapidFire 365 High-Throughput Mass Spectrometry System

Zalicus Plans to Advance Clinical Development of Z944

Debut of Kinexus' DrugKiNET KnowledgeBase

Evotec Establishes Alliance with Harvard University to Develop Novel Antibacterial Agents

UCSF Turns to be the First Partner of Pfizer's CTI in Both Small-Molecule and Biologics Discovery

In-House Development of Various Novel Antiviral Drugs from Achillion

Launch of Thermo Fisher Scientific's Drug Discovery and Biopharma Production Innovations

Sareum Partners with SRI International for Advancing the Clinical Development of Tyrosine Kinase 2 Small Molecule Drug Discovery Program

Launch of Hudson Robotics' High Efficiency Screening, an Advanced Drug Discovery Technology

Accelrys Insight and Accelrys Insight for Excel Drug Discovery Softwares from Accelrys, Inc

Renewal of Evotec and Genentech's Drug Discovery Collaboration

Alchemia, AstraZeneca Form Multi-Target Drug Discovery Pact

RaQualia Establishes Research Alliance with Interprotein to Discover PPI Inhibitor

Collaborative Effort of Evotec and Ono Yields Novel Compounds for Preclinical Development

Galapagos Takeover Cangenix Assets

EMD Millipore's Novel Genomic Biomarker Services

Marketing of an Advanced Metabolite-Identification Platform by Agilent and Molecular Discovery

QuantiGene® ViewRNA Assay Platform-based Novel Cancer Biomarker Tests Co-developed by Affymetrix and MGH

Numerate and Merck Partnered to Discover Drug Leads for Cardiovascular Disease Target

Evotec Partners with IR Pharma to Offer Drug Discovery Solutions in the Area of Respiratory Diseases

6. GLOBAL MARKET OVERVIEW6.1. Global Market Overview by Technology6.1.1 Drug Discovery Technology Overview by Global Region6.1.1.1 Bioanalytical Assays6.1.1.2 Bioinformatics6.1.1.3 Cell Based Assays6.1.1.4 Genomic Technologies6.1.1.5 High Throughput Screening6.1.1.6 Proteomic Technologies6.1.1.7 Other Drug Discovery Technologies

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

1. THE UNITED STATES

1.1 United States Market Overview by Technology

1.2 Major Market Players

Abbott Laboratories

Accelrys, Inc.

Affymetrix Inc.

Agenus Inc.

Agilent Technologies Inc.

Albany Molecular Research, Inc.

Arqule Inc.

Aviva Biosciences Corp.

BD Biosciences

Beckman Coulter Inc.

Bioanalytical Systems, Inc.

Bio-Rad Laboratories, Inc.

Biovision, Inc.

Bristol-Myers Squibb Company

Bruker Corporation

Caliper Life Sciences, Inc.

Capital Genomix, Inc.

Celera Corporation

Celgene Corporation

Charles River Laboratories International, Inc.

Discoverx Corporation

Discovery Genomics, Inc.

EMD Millipore Corporation

Hudson Robotics, Inc.

Illumina Inc.

Incyte Corporation

Isis Pharmaceuticals, Inc.

Life Technologies Corporation

Luminex Corporation

Maxcyte, Inc

Merck & Co., Inc.

Millennium Pharmaceuticals, Inc.

Molecular Devices, LLC

New England Biolabs, Inc.

Osiris Therapeutics Inc.

Perkinelmer, Inc.

Promega Corporation

Sigma-Aldrich Corporation

SRI Biosciences

Thermo Fisher Scientific Inc.

Waters Corp.

2. EUROPE2.1 European Market Overview by Technology2.2 Major Market Players4-Antibody AG (Switzerland)Astrazeneca Plc (United Kingdom)Bayer Healthcare AG (Germany)Biacore International AB (Sweden)Biofocus Dpi, Ltd (United Kingdom)Boehringer Ingelheim GmbH (Germany)Decode Genetics, Inc. (Iceland)Evotec AG (Germany)GE Healthcare Ltd. (United Kingdom)Genedata AG (Switzerland)Molecular Discovery Ltd. (Italy)Novartis AG (Switzerland)Qiagen N.V. (The Netherlands)Quantum Pharmaceuticals (Russia)Roche Holding AG (Switzerland)Tecan Group Ltd. (Switzerland)

3. ASIA-PACIFIC

3.1 Asia-Pacific Market Overview by Technology

3.2 Major Market Players

Asahi Kasei Pharma Corporation (Japan)

Hitgen Ltd (China)

Kyowa Hakko Kirin Co., Ltd. (Japan)

Molecular Discovery Systems Pty., Ltd. (Australia)

Shimadzu Corporation (Japan)

The National Center for Drug Screening (China)

Viva Biotech Ltd (China)

4. REST OF WORLD4.1 Rest of World Market Overview by Technology4.2 Major Market PlayersCaprion Proteomics, Inc. (Canada)Compugen Ltd. (Israel)Pluristem Therapeutics Inc. (Israel)

PART C: GUIDE TO THE INDUSTRY

1. NORTH AMERICA

1.1 Canada

1.2 United States

2. EUROPE

2.1 Belgium

2.2 Denmark

2.3 France

2.4 Germany

2.5 Iceland

2.6 Ireland

2.7 Italy

2.8 Russia

2.9 Sweden

2.10 Switzerland

2.11 The Netherlands

2.12 The United Kingdom

3. ASIA-PACIFIC

3.1 Australia

3.2 China

3.3 India

3.4 Japan

3.5 Singapore

3.6 Taiwan

4. REST OF WORLD

4.1 Israel

PART D: ANNEXURE1. RESEARCH METHOLOGY2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVEChart 1: Global Drug Discovery Technologies Market Analysis (2010-2020) in USD MillionChart 2: Global Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 3: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other TechnologiesChart 4: Global Market for Bioanalytical Assays in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 5: Glance at 2010, 2015 and 2020 Global Market Share of Bioanalytical Assays in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 6: Global Market for Bioinformatics in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 7: Glance at 2010, 2015 and 2020 Global Market Share of Bioinformatics in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 8: Global Market for Cell Based Assays in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 9: Glance at 2010, 2015 and 2020 Global Market Share of Cell Based Assays in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 10: Global Market for Genomic Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 11: Glance at 2010, 2015 and 2020 Global Market Share of Genomic Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 12: Global Market for High Throughput Screening in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 13: Glance at 2010, 2015 and 2020 Global Market Share of High Throughput Screening in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 14: Global Market for Proteomic Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 15: Glance at 2010, 2015 and 2020 Global Market Share of Proteomic Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of WorldChart 16: Global Market for Other Drug Discovery Technologies in Drug Discovery (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD MillionChart 17: Glance at 2010, 2015 and 2020 Global Market Share of Other Drug Discovery Technologies in Drug Discovery (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

Chart 18: The Projection of Largest Regions in terms of Market Growth for Drug Discovery Technologies by Geography – Asia-Pacific, Europe and United States

Chart 19: Global Drug Discovery Technologies Market Analysis (2010-2020) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World in USD Million

Chart 20: Glance at 2010, 2015 and 2020 Global Drug Discovery Technologies Market Share (%) by Geographic Region – United States, Europe, Asia-Pacific and Rest of World

THE UNITED STATESChart 21: United States Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 22: Glance at 2010, 2015 and 2020 United States Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

EUROPE

Chart 23: European Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million

Chart 24: Glance at 2010, 2015 and 2020 European Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

ASIA-PACIFICChart 25: Asia-Pacific Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD MillionChart 26: Glance at 2010, 2015 and 2020 Asia-Pacific Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

REST OF WORLD

Chart 27: Rest of World Drug Discovery Technologies Market Analysis (2010-2020) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies in USD Million

Chart 28: Glance at 2010, 2015 and 2020 Rest of World Drug Discovery Technologies Market Share (%) by Discovery Technology – Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Other Technologies

Table 1: Prominent Technologies used for Bioanalytical ResearchTable 2: Prominent Types of Cell Based Assays used in High Throughput Screening

To order this report:  Drug Discovery Technologies - A Global Market Overview

http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html 

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...
With so much going on in this space you could be forgiven for thinking you were always working with yesterday’s technologies. So much change, so quickly. What do you do if you have to build a solution from the ground up that is expected to live in the field for at least 5-10 years? This is the challenge we faced when we looked to refresh our existing 10-year-old custom hardware stack to measure the fullness of trash cans and compactors.
Extreme Computing is the ability to leverage highly performant infrastructure and software to accelerate Big Data, machine learning, HPC, and Enterprise applications. High IOPS Storage, low-latency networks, in-memory databases, GPUs and other parallel accelerators are being used to achieve faster results and help businesses make better decisions. In his session at 18th Cloud Expo, Michael O'Neill, Strategic Business Development at NVIDIA, focused on some of the unique ways extreme computing is...
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions wi...
DevOps at Cloud Expo, taking place Nov 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 19th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long dev...
Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is expected in the amount of information being processed, managed, analyzed, and acted upon by enterprise IT. This amazing is not part of some distant future - it is happening today. One report shows a 650% increase in enterprise data by 2020. Other estimates are even higher....
I wanted to gather all of my Internet of Things (IOT) blogs into a single blog (that I could later use with my University of San Francisco (USF) Big Data “MBA” course). However as I started to pull these blogs together, I realized that my IOT discussion lacked a vision; it lacked an end point towards which an organization could drive their IOT envisioning, proof of value, app dev, data engineering and data science efforts. And I think that the IOT end point is really quite simple…
Aspose.Total for .NET is the most complete package of all file format APIs for .NET as offered by Aspose. It empowers developers to create, edit, render, print and convert between a wide range of popular document formats within any .NET, C#, ASP.NET and VB.NET applications. Aspose compiles all .NET APIs on a daily basis to ensure that it contains the most up to date versions of each of Aspose .NET APIs. If a new .NET API or a new version of existing APIs is released during the subscription peri...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
Qosmos has announced new milestones in the detection of encrypted traffic and in protocol signature coverage. Qosmos latest software can accurately classify traffic encrypted with SSL/TLS (e.g., Google, Facebook, WhatsApp), P2P traffic (e.g., BitTorrent, MuTorrent, Vuze), and Skype, while preserving the privacy of communication content. These new classification techniques mean that traffic optimization, policy enforcement, and user experience are largely unaffected by encryption. In respect wit...
Kubernetes, Docker and containers are changing the world, and how companies are deploying their software and running their infrastructure. With the shift in how applications are built and deployed, new challenges must be solved. In his session at @DevOpsSummit at19th Cloud Expo, Sebastian Scheele, co-founder of Loodse, will discuss the implications of containerized applications/infrastructures and their impact on the enterprise. In a real world example based on Kubernetes, he will show how to ...
Using new techniques of information modeling, indexing, and processing, new cloud-based systems can support cloud-based workloads previously not possible for high-throughput insurance, banking, and case-based applications. In his session at 18th Cloud Expo, John Newton, CTO, Founder and Chairman of Alfresco, described how to scale cloud-based content management repositories to store, manage, and retrieve billions of documents and related information with fast and linear scalability. He addres...
Is the ongoing quest for agility in the data center forcing you to evaluate how to be a part of infrastructure automation efforts? As organizations evolve toward bimodal IT operations, they are embracing new service delivery models and leveraging virtualization to increase infrastructure agility. Therefore, the network must evolve in parallel to become equally agile. Read this essential piece of Gartner research for recommendations on achieving greater agility.
SYS-CON Events announced today that Hitrons Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Hitrons Solutions Inc. is distributor in the North American market for unique products and services of small and medium-size businesses, including cloud services and solutions, SEO marketing platforms, and mobile applications.